CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 12 enrolled
Drug / intervention
Sevoflurane +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03503578
NCT03503578Phase 2Completed
CompareCT.gov

Electroencephalogram Studies of Induction and Recovery From Sevoflurane-Induced General Anesthesia

Massachusetts General Hospital·interventional·Posted Apr 20, 2018·Updated Oct 24, 2019

In Brief

A Phase 2 clinical trial evaluating Sevoflurane and Ketamine for Anesthesia. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The investigators are performing this research study to find out how and where the anesthetic drugs sevoflurane and ketamine act in the brain. Sevoflurane and ketamine are anesthetics (a drug or agent used to decrease or eliminate the feeling of pain by causing unconsciousness). The investigators will study the brain using a machine that records the brain's electrical activity, called an electroencephalogram (EEG).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnesthesia
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedApr 20, 2018
Enrollment StartMay 1, 2018
Primary CompletionAug 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.2 years ago

Interventions

Sevofluranedrug

Subjects will received sevoflurane for approximately 60 minutes.

Ketaminedrug

Subjects will received sevoflurane and ketamine for approximately 60 minutes.